[Neuroprotection by ketamine and dopamine-saving drugs in severe craniocerebral trauma at exacerbation and in the treatment of apallic syndrome].
Vereshchagin
E I
EI
Tarasov
R S
RS
Astrakov
S V
SV
Lokotkova
O V
OV
Egorov
A V
AV
Volkov
S G
SG
Vereshchagin
I P
IP
D003128:Coma / Q000188:drug therapy*; D006259:Craniocerebral Trauma / Q000188:drug therapy*; D015259:Dopamine Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007649:Ketamine / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D019798:Neopterin / Q000134:cerebrospinal fluid; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D013501:Surface-Active Agents / Q000032:analysis; D013577:Syndrome; D020196:Trauma, Nervous System / Q000188:drug therapy
D015259:Dopamine Agents; D018696:Neuroprotective Agents; D013501:Surface-Active Agents; D019798:Neopterin; D007649:Ketamine